Prognostic significance of the combination of preoperative fibrinogen and the neutrophil‑lymphocyte ratio in patients with non‑small cell lung cancer following surgical resection

Liang,Hua‑Gang; Gao,Kun; Jia,Rui; Li,Jian; Wang,Chao

doi:10.3892/ol.2018.9760

Prognostic significance of the combination of preoperative fibrinogen and the neutrophil‑lymphocyte ratio in patients with non‑small cell lung cancer following surgical resection

Authors:
- Hua‑Gang Liang
- Kun Gao
- Rui Jia
- Jian Li
- Chao Wang
View Affiliations

Affiliations: Department of Thoracic Surgery, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei 066000, P.R. China
Published online on: November 26, 2018 https://doi.org/10.3892/ol.2018.9760
Pages: 1435-1444
Copyright: © Liang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The purpose of the present study was to evaluate the prognostic value of preoperative coagulation factor levels (including fibrinogen and D‑dimer) and inflammatory indicators in patients with non‑small cell lung cancer (NSCLC). The medical records of 456 patients with NSCLC who had undergone curative resection were retrospectively analysed. The recommended cut‑off values for preoperative fibrinogen, neutrophil‑lymphocyte ratio (NLR), platelet‑lymphocyte ratio and lymphocyte‑monocyte ratio were determined using receiver operating characteristic curve analyses. The associations between preoperative fibrinogen or D‑dimer levels and clinicopathological variables were analysed using the χ2 test. Univariate Kaplan‑Meier analysis and a multivariate Cox proportional hazards model were applied to identify which prognostic variables were significantly associated with overall survival (OS) rates. Multivariate analyses revealed that lymph node metastasis (P<0.001), preoperative fibrinogen (P=0.024) and NLR (P=0.028) were effective independent prognostic variables associated with OS. Based on this result, a novel, single inflammation‑based combination of fibrinogen and NLR (COF‑NLR) score was proposed for the determination of prognosis. Patients with elevated fibrinogen and NLR levels were allocated a score of 2 (n=136), and those that demonstrated elevated levels of one or neither were allocated a score of 1 (n=152) or 0 (n=168), respectively. The 5‑year OS rates were significantly poorer for patients with COF‑NLR=2 compared with those with COF‑NLR=1 or 0 (23.5% vs. 34.2% vs. 50.0%, P<0.001). A subgroup analysis demonstrated that the prognostic significance of COF‑NLR was independent of histological subtype, lymph node metastasis and pathological stage. Therefore, COF‑NLR has potential as a novel and useful blood marker for predicting tumour progression and the postoperative survival of patients with NSCLC. It may assist clinicians in risk stratification, prognosis predictions and facilitating individualised treatment.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
2	Kamangar F, Dores GM and Anderson WF: Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
3	Zeng Q, Xue N, Dai D, Xing S, He X, Li S, Du Y, Huang C, Li L and Liu W: A nomogram based on inflammatory factors C-reactive protein and fibrinogen to predict the prognostic value in patients with resected non-small cell lung cancer. J Cancer. 8:744–753. 2017. View Article : Google Scholar : PubMed/NCBI
4	Murray JC: Coagulation and cancer. Br J Cancer. 64:422–424. 1991. View Article : Google Scholar : PubMed/NCBI
5	Son HJ, Park JW, Chang HJ, Kim DY, Kim BC, Kim SY, Park SC, Choi HS and Oh JH: Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer. Ann Surg Oncol. 20:2908–2913. 2013. View Article : Google Scholar : PubMed/NCBI
6	Vahid DM, Ahmari S, Alipour S and Tehranian A: The comparison of plasma D-dimer levels in benign and malignant tumors of cervix, ovary and uterus. Int J Hematol Oncol Stem Cell Res. 9:107–111. 2015.PubMed/NCBI
7	Nakamura K, Nakayama K, Ishikawa M, Katagiri H, Minamoto T, Ishibashi T, Ishikawa N, Sato E, Sanuki K, Yamashita H, et al: High pre-treatment plasma D-Dimer level as a potential prognostic biomarker for cervical carcinoma. Anticancer Res. 36:2933–2938. 2016.PubMed/NCBI
8	Dirix LY, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, van Dam P, Prové A, Lemmens J and Vermeulen P: Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer. 86:389–395. 2002. View Article : Google Scholar : PubMed/NCBI
9	Dunn GP, Old LJ and Schreiber RD: The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 21:137–148. 2004. View Article : Google Scholar : PubMed/NCBI
10	McMillan DC: Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 12:223–226. 2009. View Article : Google Scholar : PubMed/NCBI
11	Arigami T, Uenosono Y, Matsushita D, Yanagita S, Uchikado Y, Kita Y, Mori S, Kijima Y, Okumura H, Maemura K, et al: Combined fibrinogen concentration and neutrophil-lymphocyte ratio as a prognostic marker of gastric cancer. Oncol Lett. 11:1537–1544. 2016. View Article : Google Scholar : PubMed/NCBI
12	Arigami T, Okumura H, Matsumoto M, Uchikado Y, Uenosono Y, Kita Y, Owaki T, Mori S, Kurahara H, Kijima Y, et al: Analysis of the fibrinogen and neutrophil-lymphocyte ratio in esophageal squamous cell carcinoma: A promising blood marker of tumor progression and prognosis. Medicine (Baltimore). 94:e17022015. View Article : Google Scholar : PubMed/NCBI
13	Fu SJ, Ji F, Han M, Chen MG, Wang XP, Ju WQ, Zhao Q, Wu LW, Ren QQ, Guo ZY, et al: Prognostic value of combined preoperative fibrinogen and neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma after liver transplantation. Oncotarget. 8:4301–4312. 2017.PubMed/NCBI
14	Xia H, Sun Z, Deng L, Zhu D and Wang D: Prognostic significance of the preoperative lymphocyte to monocyte ratio in patients with stage I non-small cell lung cancer undergoing complete resection. Cancer Invest. 34:378–384. 2016. View Article : Google Scholar : PubMed/NCBI
15	Dorn-Beineke A, Dempfle CE, Bertsch T and Wisser H: Evaluation of the automated coagulation analyzer Sysmex CA-7000. Thromb Res. 116:171–179. 2005. View Article : Google Scholar : PubMed/NCBI
16	Tian S: Classification and survival prediction for early-stage lung adenocarcinoma and squamous cell carcinoma patients. Oncol Lett. 14:5464–5470. 2017.PubMed/NCBI
17	Fang L, Sheng H, Wan D, Zhu C, Jiang R, Sun X and Feng J: Prognostic role of multidrug resistance-associated protein 1 expression and platelet count in operable non-small cell lung cancer. Oncol Lett. 16:1123–1132. 2018.PubMed/NCBI
18	Zou Q, Wang T, Li B, Li G, Zhang L, Wang B and Sun S: Overexpression of circ-0067934 is associated with increased cellular proliferation and the prognosis of non-small cell lung cancer. Oncol Lett. 16:5551–5556. 2018.PubMed/NCBI
19	Yamashita H, Kitayama J, Kanno N, Yatomi Y and Nagawa H: Hyperfibrinogenemia is associated with lymphatic as well as hematogenous metastasis and worse clinical outcome in T2 gastric cancer. BMC Cancer. 6:1472006. View Article : Google Scholar : PubMed/NCBI
20	Palumbo JS: Mechanisms linking tumor cell-associated procoagulant function to tumor dissemination. Semin Thromb Hemost. 34:154–160. 2008. View Article : Google Scholar : PubMed/NCBI
21	Lal I, Dittus K and Holmes CE: Platelets, coagulation and fibrinolysis in breast cancer progression. Breast Cancer Res. 15:2072013. View Article : Google Scholar : PubMed/NCBI
22	Weisel JW: Fibrinogen and fibrin. Adv Protein Chem. 70:247–299. 2005. View Article : Google Scholar : PubMed/NCBI
23	Arpaia G, Carpenedo M, Verga M, Mastrogiacomo O, Fagnani D, Lanfredini M, Milani M and Cimminiello C: D-dimer before chemotherapy might predict venous thromboembolism. Blood Coagul Fibrinolysis. 20:170–175. 2009. View Article : Google Scholar : PubMed/NCBI
24	Yamaguchi T, Yamamoto Y, Yokota S, Nakagawa M, Ito M and Ogura T: Involvement of interleukin-6 in the elevation of plasma fibrinogen levels in lung cancer patients. Jpn J Clin Oncol. 28:740–744. 1998. View Article : Google Scholar : PubMed/NCBI
25	Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, Alaniz L, Aquino JB, Fiore E, Rizzo MM, Rodriguez A, et al: Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Mol Pharm. 8:1538–1548. 2011. View Article : Google Scholar : PubMed/NCBI
26	Zheng S, Shen J, Jiao Y, Liu Y, Zhang C, Wei M, Hao S and Zeng X: Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci. 100:859–865. 2009. View Article : Google Scholar : PubMed/NCBI
27	Vesely MD and Schreiber RD: Cancer immunoediting: Antigens, mechanisms, and implications to cancer immunotherapy. Ann N Y Acad Sci. 1284:1–5. 2013. View Article : Google Scholar : PubMed/NCBI
28	Wu G, Yao Y, Bai C, Zeng J, Shi D, Gu X, Shi X and Song Y: Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients. Thorac Cancer. 6:275–287. 2015. View Article : Google Scholar : PubMed/NCBI
29	Lee S, Oh SY, Kim SH, Lee JH, Kim MC, Kim KH and Kim HJ: Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 13:3502013. View Article : Google Scholar : PubMed/NCBI
30	Hirahara N, Matsubara T, Mizota Y, Ishibashi S and Tajima Y: Prognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomy. BMC Surg. 16:662016. View Article : Google Scholar : PubMed/NCBI
31	Neagoe PE, Brkovic A, Hajjar F and Sirois MG: Expression and release of angiopoietin-1 from human neutrophils: Intracellular mechanisms. Growth Factors. 27:335–344. 2009. View Article : Google Scholar : PubMed/NCBI
32	Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT and Whiteside TL: Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res. 8:2553–2562. 2002.PubMed/NCBI
33	Gabazza E, Taguchi O, Yamakami T, Machishi M, Ibata H and Suzuki S: Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer. Cancer. 72:2134–2140. 1993. View Article : Google Scholar : PubMed/NCBI
34	Ma C, Lu B, Diao C, Zhao K, Wang X, Ma B, Lu B and Sun E: Preoperative neutrophil-lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer. Onco Targets Ther. 9:4917–4922. 2016. View Article : Google Scholar : PubMed/NCBI
35	Kijima T, Arigami T, Uchikado Y, Uenosono Y, Kita Y, Owaki T, Mori S, Kurahara H, Kijima Y, Okumura H, et al: Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma. Cancer Sci. 108:193–199. 2017. View Article : Google Scholar : PubMed/NCBI